The acute effect of fludrocortisone on basal and hCRH-stimulated hypothalamic–pituitary–adrenal (HPA) axis in humans

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Pituitary

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11102-012-0435-3PMID 23011321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.

  2010cited by this paper
• Dynamics of Glucocorticoid and Mineralocorticoid Receptors in the Xenopus laevis Pituitary Pars Intermedia

  2009cited by this paper
• Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline

  2009cited by this paper
• Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

  2008cited by this paper
• Primary hyperaldosteronism is associated with derangement in the regulation of the hypothalamus-pituitary-adrenal axis in humans

  2007cited by this paper
• The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.

  2007influential reference
• Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade.

  2005cited by this paper
• Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans.

  2004cited by this paper
• Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.

  2004cited by this paper
• Mineralo- and Glucocorticoid Receptor mRNAs Are Differently Regulated by Corticosterone in the Rat Hippocampus and Anterior Pituitary

  2004cited by this paper
• Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties.

  2004cited by this paper
• The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.

  2003influential reference
• Mineralocorticoid Receptor-Mediated Inhibition of the Hypothalamic-Pituitary-Adrenal Axis in Aged Humans

  2003cited by this paper
• Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans

  2002cited by this paper
• The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.

  2002cited by this paper
• Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain.

  2002cited by this paper
• The brain mineralocorticoid receptor: greedy for ligand, mysterious in function.

  2000cited by this paper
• Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone.

  2000influential reference
• The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans.

  1999cited by this paper
• Defense of adrenocorticosteroid receptor expression in rat hippocampus: effects of stress and strain.

  1999cited by this paper
• Mineralocorticoid Receptor also Modulates Basal Activity of Hypothalamus-Pituitary-Adrenocortical System in Humans

  1998cited by this paper
• The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans.

  1998cited by this paper
• Brain corticosteroid receptor balance in health and disease.

  1998influential reference
• Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.

  1997influential reference
• Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis.

  1996cited by this paper
• The nuclear hormone receptor gene superfamily.

  1995cited by this paper
• Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis.

  1995cited by this paper
• Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues.

  1993cited by this paper
• Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans.

  1993cited by this paper
• Corticotropin-releasing hormone in humans.

  1992cited by this paper
• Biochemical switching in hypothalamic circuits mediating responses to stress.

  1991cited by this paper
• The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.

  1991influential reference
• Functional biology of intestinal goblet cells.

  1991cited by this paper
• Gluco- and antimineralocorticoid effects on human sleep: a role of central corticosteroid receptors.

  1991cited by this paper
• On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.

  1989cited by this paper
• Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors.

  1989cited by this paper
• Stress and the pituitary-adrenal axis.

  1987cited by this paper
• The CRH Motoneuron: Differential Peptide Regulation in Neurons with Possible Synaptic, Paracrine, and Endocrine Outputs

  1987cited by this paper
• Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

  1985cited by this paper
• [Pharmacokinetics of 9 -fluorhydrocortisone].

  1971cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Mineralocorticoid Receptor Blockade by Canrenoate Increases Both Spontaneous and Stimulated Adrenal Function in Humans*

  year unknowncited by this paper

• Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia

  2023cites this paper
• Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors

  2021cites this paper
• Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy

  2017cites this paper
• 3.09 – Aldosterone Action on Brain and Behavior

  2017cites this paper
• Selective attention to emotional cues and emotion recognition in healthy subjects: the role of mineralocorticoid receptor stimulation

  2016cites this paper
• The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison’s disease

  2016cites this paper
• The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors

  2016cites this paper
• Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

  2015cites this paper
• Presence of 21-Hydroxylase Antibodies in a Boy with X-Linked Adrenal Hypoplasia Congenita

  2015cites this paper
• Overnight suppression of HPA axis after mineraolocorticoid receptor stimulation: A sleep endocrine study.

  2015influential citation
• Regulation of murine corticotroph cell excitability

  2014influential citation
• Paradoxical mineralocorticoid receptor-mediated effect in fear memory encoding and expression of rats submitted to an olfactory fear conditioning task.

  2014cites this paper
• Genetic, Molecular and Clinical Determinants for the Involvement of Aldosterone and Its Receptors in Major Depression

  2014cites this paper